AHA today urged the Drug Enforcement Administration to release its proposed rules outlining a special registration process for prescribing medically necessary controlled substances via telehealth after the COVID-19 public health emergency; provide an interim plan to support continuity of care if the PHE expires before the rules are finalized; and grant a permanent exception for separate registrations for practitioners in states that have medical licensing reciprocity requirements.

“[T]here is growing concern that the pending expiration of the COVID-19 PHE and its associated waivers, combined with the lack of a special registration regulation, will leave providers in a position where they will need to cut services and leave patients without access to necessary treatment,” AHA wrote. “With the expiration of the COVID-19 PHE currently scheduled for next year, this situation could come to pass as early as mid-January.”

Related News Articles

Headline
As the Congressional Telehealth Caucus considers updates to legislation that would permanently remove all geographic restrictions on Medicare telehealth…
Headline
Forty state Medicaid programs newly allowed or expanded audio-only telehealth services for behavioral health in 2022, and 39 expanded the types of behavioral…
Headline
The AHA today released its 2023 Environmental Scan, which provides key data and insights on the current health care landscape and can help organizations…
Perspective
As Congress convenes for its post-election lame-duck session, we are turning up the pressure to secure additional support for hospitals and the patients and…
Headline
Medicare patients who accessed opioid use disorder treatment through telehealth services during the pandemic were more likely to stay in treatment and less…
Headline
The departments of Health and Human Services and Justice today released guidance on federal telehealth protections for people with disabilities and limited…